高级检索
当前位置: 首页 > 详情页

Risk factors for 28-day mortality in patients with sepsis-related myocardial injury in intensive care units

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE ◇ 预警期刊

单位: [1]Department of Critical Care Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, China
出处:
ISSN:

关键词: Acute Physiology and Chronic Health Evaluation II (APACHE II) score myocardial injury sepsis acute kidney injury norepinephrine mortality

摘要:
Objective This study aimed to identify the risk factors for death in patients with sepsis-related myocardial injury. Methods A retrospective study was conducted in 158 patients with sepsis-related myocardial injury in a mixed medical intensive care unit from January 2009 to March 2020. The patients were divided into those who survived and those who died on the basis of whether they survived after 28 days. Demographic and clinical parameters were collected. Multivariate logistic regression was performed. Results Sixty-nine (43.7%) patients died within 28 days after admission to the intensive care unit. Multivariate logistic regression analysis showed that the oxygenation index (odds ratio [OR]: 0.979, 95% confidence interval [CI]: 0.970-0.989), acute kidney injury (OR: 4.787, 95% CI: 1.674-13.693), norepinephrine dose (OR: 1.706, 95% CI: 1.375-2.117), and abdominopelvic cavity infection (OR: 0.257, 95% CI: 0.076-0.866) were significantly associated with mortality within 28 days after admission in patients with sepsis-related myocardial injury. Conclusions Patients with sepsis-related myocardial injury have a high mortality rate. A high oxygenation index, occurrence of acute kidney injury, high norepinephrine dose, and occurrence of abdominopelvic cavity infection are independent risk factors for 28-day mortality in patients with sepsis-related myocardial injury.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 药学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 药学
JCR分区:
出版当年[2019]版:
Q4 MEDICINE, RESEARCH & EXPERIMENTAL Q4 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q4 MEDICINE, RESEARCH & EXPERIMENTAL Q4 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2019版] 出版当年五年平均[2015-2019] 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者单位: [1]Department of Critical Care Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, China
通讯作者:
通讯机构: [1]Department of Critical Care Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, China [*1]Department of Critical Care Medicine, Beijing Friendship Hospital, Capital Medical University, No. 95 Yongan Road, Xicheng District, Beijing 100050, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)